These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1782327)
21. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG). Graus YM; van Breda Vriesman PJ; de Baets MH Clin Exp Immunol; 1993 Jun; 92(3):506-13. PubMed ID: 8513583 [TBL] [Abstract][Full Text] [Related]
22. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis. Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300 [TBL] [Abstract][Full Text] [Related]
23. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis. Barkas T; Simpson JA Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Lennon VA; Lambert EH Ann N Y Acad Sci; 1981; 377():77-96. PubMed ID: 6176167 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis. Vernet-der Garabedian B; Morel E; Bach JF J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity. Tzartos S; Langeberg L; Hochschwender S; Swanson LW; Lindstrom J J Neuroimmunol; 1986 Jan; 10(3):235-53. PubMed ID: 3484485 [TBL] [Abstract][Full Text] [Related]
27. Alteration of the humoral immune response against muscle acetylcholine receptor by timed administration of alpha(1----3)dextran. Tong Z; Dwyer DS Eur J Immunol; 1990 Aug; 20(8):1627-34. PubMed ID: 1698629 [TBL] [Abstract][Full Text] [Related]
28. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Araga S; LeBoeuf RD; Blalock JE Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359 [TBL] [Abstract][Full Text] [Related]
30. Immunisation with Torpedo acetylcholine receptor. Elfman L Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937 [TBL] [Abstract][Full Text] [Related]
31. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis. Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920 [TBL] [Abstract][Full Text] [Related]
32. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis. Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231 [TBL] [Abstract][Full Text] [Related]
33. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Lennon VA; Griesmann GE Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772 [TBL] [Abstract][Full Text] [Related]
34. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis. Lefvert AK J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109 [TBL] [Abstract][Full Text] [Related]
35. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Graus YM; Verschuuren JJ; Bos NA; van Breda Vriesman PJ; De Baets MH J Neuroimmunol; 1993 Mar; 43(1-2):113-24. PubMed ID: 8458983 [TBL] [Abstract][Full Text] [Related]
38. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. Wang ZY; Link H; Qiao J; Olsson T; Huang WX J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155 [TBL] [Abstract][Full Text] [Related]
39. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies. Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702 [TBL] [Abstract][Full Text] [Related]
40. Anti-presynaptic membrane receptor antibodies in myasthenia gravis. Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]